14
Jul

A Lifelong Dedication to Cancer

When Alison Petok was five years old, her Nana died of leukemia. “If she had been diagnosed a decade or two later, perhaps she would have survived due to the advances in blood cancer research,” Alison reflected. Years later in 2017, Alison was nominated as “Woman of the Year” by The Leukemia & Lymphoma Society …

11
Jul

Understanding Chemotherapy Resistance in Pancreatic Cancer

A collaborative study involving Sidney Kimmel Cancer Center at Jefferson (SKCC) investigators, together with colleagues from the University of California at San Diego, has provided important insights into how pancreatic cancer cells are able to resist the effects of chemotherapeutic agents. The new study, published in Cancer Research, was led by senior author Jordan Winter, MD, FACS, Associate Professor of …

23
Jun

Important New Insights into Key Regulatory Pathway for Cancer Cell Survival

New research from the laboratory of Christine Eischen, PhD, Co-Leader of the Molecular Biology and Genetics Program at the Sidney Kimmel Cancer Center at Jefferson, has revealed a previously unappreciated feature of a well-known cell survival mechanism with potentially important implications for the treatment of some cancers. The study, recently published in Cancer Research, focuses on the …

5
May

Getting Personal about Inherited Risk for Prostate Cancer

A new study published in JCO Precision Oncology by lead investigator Veda N. Giri, MD, at the Sidney Kimmel Cancer Center at Jefferson takes an important step in deciphering the genetic landscape contributing to inherited prostate cancer. Genetic Evaluation of Men (GEM) is a study focused on uncovering the genetic contribution to inherited prostate cancer. …

4
May

Kathleen O’Doherty Joins SKCC In Joint Navigator Position

We are excited to announce that Kathleen O’Doherty, RN, BSN, OCN, has joined us in the role of Nursing Care Coordinator: Oncology Outreach, a joint navigator position between Main Line Health Cancer Care and The Sidney Kimmel Cancer Center at Jefferson. Kathleen will work closely with physicians and members of the multidisciplinary care teams at both institutions …

1
May

Dr. Veda Giri Featured on Congressional Directed Medical Research Programs Website

The research of Sidney Kimmel Cancer Center investigator Veda Giri, MD, has been highlighted on the Congressionally Directed Medical Research Programs (CDMRP) website. Giri and her team received funding from the U.S. Department of Defense Prostate Cancer Research Program (PCRP) to conduct studies on men at high risk for aggressive prostate cancer.  She and her …

28
Apr

Opening Up Chromatin for Cell Differentiation

Two new studies from the laboratory of Alex Mazo, PhD, at the Sidney Kimmel Cancer Center, along with collaborators from SKCC, the Vickie and Jack Farber Institute for Neuroscience at Thomas Jefferson University, and other institutions, provide new insights into the structure of chromatin and its implications for cellular differentiation.  The new work, appearing in …

25
Apr

New Insights into G Protein-Coupled Receptor Signaling and Regulation

A collaborative study by the laboratories of Jeffrey L. Benovic, PhD,  in the Department of Biochemistry and Molecular Biology at Thomas Jefferson University and the Sidney Kimmel Cancer Center at Jefferson, and Dr. Brian K. Kobilka in the Department of Molecular and Cellular Physiology at the Stanford University School of Medicine provides new insights into a …

5
Apr

Promising New Results in Lung Cancer Research

Investigators at the Sidney Kimmel Cancer Center at Jefferson have uncovered a new regulatory pathway with important implications for lung cancer. Lung cancer is the leading cause of all cancer-related deaths worldwide, with 85% of all cases consisting of non-small cell lung cancer (NSCLC). A major obstacle to successfully treating NSCLC  is that many patients …

30
Mar

2017 Ocular Melanoma Foundation–AACR Fellowship Awarded to Vivian Chua

The Sidney Kimmel Cancer Center at Jefferson is pleased to announce that Vivian Chua, PhD, has been awarded a 2017 Ocular Melanoma Foundation–American Associate for Cancer Research (AACR) Fellowship for her project, “Novel Epigenetic Targeting Approaches in Uveal Melanoma.” This one-year, $50,000 grant recognizes the significant impact of Dr. Chua’s research, its relevance to the …

29
Mar

Christine Bonaccorso Named Administrative Director of Sidney Kimmel Cancer Network

Please join us in congratulating Christine Bonaccorso, RN, BSN, OCN, on assuming the position of Administrative Director of the Sidney Kimmel Cancer Network. Over the past several months, Bonaccorso has proven to be an outstanding leader while serving as Interim Director, playing a critical role in several projects that have greatly enhanced the Cancer Network. …

24
Mar

Noelle Williams Inducted into Gold Humanism Honor Society

The Sidney Kimmel Cancer Center at Jefferson would like to congratulate Noelle L. Williams, MD, who has been selected for induction into the Gold Humanism Honor Society Resident Chapter of Thomas Jefferson University. The Gold Humanism Honor Society recognizes students, residents, and faculty who are exemplars of compassionate patient care and who serve as role …

23
Mar

Ralph Zinner and Amy Leader Awarded ACT Research Grant from Free to Breathe

The Sidney Kimmel Cancer Center at Jefferson is pleased to announce that Ralph Zinner, MD, and Amy Leader, DrPH, MPH, are the winners of the second Accelerate Clinical Trials (ACT) Research Grant Award from Free to Breathe, an organization devoted to improving the treatment and survival of lung cancer patients.  The ACT grant is a funding …

21
Mar

Unite for HER Wellness Day – April 2, 2017

  The Sidney Kimmel Cancer Center at Jefferson encourages Jefferson Hospital System breast cancer patients to participate in the upcoming “Unite for HER Wellness Day” event to be held on Sunday, April 2, 2017. This event will allow breast cancer patients to meet in a small group setting with trained professionals to learn about complementary …

15
Mar

RNA-Regulated Mechanism Validated as a Target in GI Tract Cancers

Investigators from the Sidney Kimmel Cancer Center at Jefferson, Thomas Jefferson University, and Drexel University have uncovered a critical regulatory mechanism involved in pancreatic and colorectal cancer progression. The study results were recently published in Molecular Cancer Research. The researchers investigated the role of the RNA-binding protein HuR (also known as ELAVL1) in gastrointestinal (GI) …

17
Feb

Researchers Build Pan-Cancer Biomarker Tool to Categorize Multiple Cancer Types

Researchers at the Sidney Kimmel Cancer Center at Jefferson recently discovered that isomiRs (small non-coding RNA molecules produced in a cell) are powerful enough to accurately classify samples that can belong to 32 types of cancer. The research was published in the journal Nucleic Acids Research. Work in recent years has revealed that microRNAs (miRNAs), small …

27
Jan

The Sidney Kimmel Cancer Center at Jefferson Welcomes Pierluigi Porcu

The Sidney Kimmel Cancer Center at Jefferson is pleased to announce the appointment of Pierluigi Porcu, MD, as the new Director of the Hematologic Malignancies and Hematopoietic Stem Cell Transplantation Division in the Department of Medical Oncology, effective December 1, 2016. Dr. Porcu comes to Jefferson from The Ohio State University in Columbus, where he …

18
Jan

Doylestown Health Joins Sidney Kimmel Cancer Network at Jefferson

The Sidney Kimmel Cancer Network at Jefferson and Doylestown Health will officially join forces effective January 1, 2017. The affiliation combines the expertise of a leading academic medical center and a community health system with a reputation for delivering quality health care. As the newest member of the Sidney Kimmel Cancer Network (SKCN) at Jefferson, …

13
Jan

Maria Werner-Wasik Receives New Jefferson Appointments

The Sidney Kimmel Cancer Center at Jefferson is pleased to announce that Maria Werner-Wasik, MD, FASTRO, has been appointed to the position of Executive Vice Chair for Radiation Oncology Integration and the Walter Curran Professor of Radiation Oncology.  As the Executive Vice Chair, she will focus her activities on harmonizing and integrating all clinical radiation …

7
Dec

Jefferson Breast Cancer Researcher Named Margaret Q. Landenberger Professor

Nicole Simone, MD, has been named the Margaret Q. Landenberger Professor. The professorship, which focuses on breast cancer research, was established in 2006 by the Margaret Q. Landenberger Research Foundation. Dr. Simone will be the second holder of the professorship. “Dr. Simone is a cancer research pioneer who has dedicated her entire career to discovering …

Page 1 of 5